SAN JOSE, Calif., February 20, 2024 – The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and clinical practice of radiosurgery, and the American College of Radiation Oncology (ACRO), the professional society for the practice of radiation oncology, are pleased to announce the addition of the ZAP-X® Radiosurgery System to the Distinction in Stereotactic Radiotherapy accreditation manual.
Now users of the ZAP-X Radiosurgery platform can apply for the Distinction in Stereotactic Radiotherapy accreditation.
ZAP-X was FDA cleared in 2017 and began first patient treatments in 2019. ZAP-X is the first and only vault-free SRS delivery system and is utilized for the treatment of intra-cranial and head & neck disease.
About the Distinction in Stereotactic Radiotherapy Program
The Distinction in Stereotactic Radiotherapy program is the only SRS/SBRT-dedicated accreditation review by a professional medical society that focuses on practice standards, patient management, and medical physics aspects unique to SRS/SBRT treatment.
The program was designed by professional peers with extensive experience treating patients with SRS/SBRT, with the aim to identify standards indicative of a quality practice in the field of SRS/SBRT.
The Distinction in Stereotactic Radiotherapy program currently focuses on SRS/SBRT treatments within six disease sites:
How to Apply for the Distinction in Stereotactic Radiotherapy
Centers wishing to achieve the Distinction in Stereotactic Radiotherapy need to apply and complete the ACRO Accreditation Program for radiation oncology.
The review consists of a minimum of five charts with a minimum of two charts per disease site, and peer reviewers evaluating cases within their area of expertise. In addition to the medical chart review, a physics survey process was developed by medical physicists with research development backgrounds and clinical expertise in stereotactic radiotherapy using a wide range of delivery technologies. Areas of evaluation include machinery, quality assurance, staff and training, and dose constraints specific to the delivery of SRS and SBRT treatment.
The Distinction in Stereotactic Radiotherapy is also being offered virtually, using an online process for reviewing medical charts. The virtual site visit process includes a pre-visit document review, video interviews of key personnel, virtual facility inspection, and detailed reviews of all quality metrics and all elements of the practice's quality assurance programs.
Centers interested in applying for the Distinction in Stereotactic Radiotherapy Accreditation can contact Valerie Guth at info@acro.org.
Learn more at https://acro.org/page/ACROAccreditation.
About the Radiosurgery Society®
The Radiosurgery Society (RSS) – a non-profit, independent, multi-disciplinary organization of surgeons, radiation oncologists, physicists, and allied professionals, who are dedicated to advancing the science and clinical practice of radiosurgery. Originally formed in 2002 and becoming 501(c)(6) in 2008, the Radiosurgery Society today (www.therss.org) represents members who perform stereotactic body radiotherapy and radiosurgery in hospitals and freestanding centers throughout the world.
Contacts:
Stephanie Tomei
The Radiosurgery Society®